The reality is more complex
American Diabetes Association: Medications for Type 2 Diabetes Obesity Action Coalition: Lifestyle Habits to Treat Obesity Centers for Disease Control and Prevention: About Insulin Resistance Sandy Bassin, MD Medical Reviewer Sandy Bassin, MD, is an endocrinology fellow at Mount Sinai in New York City
Wegovy is specifically approved for chronic weight management, while Ozempic and Rybelsus are primarily indicated for glycemic control in type 2 diabetes patients, with notable secondary benefits of weight reduction
The medication's primary gastrointestinal side effectsparticularly nausea, vomiting, and diarrheacan lead to dehydration if fluid intake is inadequate or losses are not appropriately replaced
Remember: the point of microdosing is not to bypass medical care
Adjacent to that, there is a growing wave of research and emerging benefits related to off-label uses in mental health care